Brief: Lakeshore Biopharma Took Action To Remove Former Chairman In China Yi Zhang From All Executive Positions
13/12/2024 01:04
Dec 12 (Reuters) - LakeShore Biopharma Co Ltd H6Z0.F :
* LAKESHORE BIOPHARMA PROVIDES UPDATE ON ONGOING CRIMINAL
INVESTIGATION INVOLVING FORMER CHAIRMAN IN CHINA
* LAKESHORE BIOPHARMA CO LTD - UNCOVERED EVIDENCE
SUGGESTING THAT
YI ZHANG MISAPPROPRIATED CORPORATE ASSETS
* LAKESHORE BIOPHARMA CO LTD - TOOK ACTION TO REMOVE YI
ZHANG FROM
ALL EXECUTIVE POSITIONS
Source text: ID:nGNX4t2Vmq
Further company coverage: H6Z0.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing